Slide 1: Third Quarter 2024 Earnings
Click Here to Edit Title Third Quarter 2024 Earnings October 30, 2024
Slide 2: Cautionary Statement; Non-GAAP Measures
Cautionary Click Here to Statement Edit TitleCautionary Statement Under the Private Securities Litigation Reform Act; Non-GAAP Measures This presentation contains “forward-looking” statements within the meaning of the Private Securities Litigation Reform Act of 1995, as amended. These statements may
Slide 3: IDEX Overview: Third Quarter Results
Click Here IDEX Overview to Edit Title Third Quarter Results • FMT growth with stable day-to-day orders…Still delays in long term commitments • FSDP record sales with strong Fire & Safety and BAND-IT growth • HST strong orders growth and backlog build led by Life Sciences • Completed Mott acquisitio
Slide 4: Diverse and Specialized Portfolio
Diverse Click Here andtoSpecialized Edit Title Portfolio Intelligent Water Trebor Recirculation DI water heaters Pulsimeter flow controls for wastewater management Envirosight inspection and monitoring solutions ADS sewer and stormwater management systems
Slide 5: Strategic Value Creation: Mott Acquisition
Strategic Click HereValue to Edit Creation Title Acquisition Mott Gas filters production and inspection clean New green hydrogen components facility room opening 5
Slide 6: Q3 2024 Financial Performance
Q3 Click 2024 Here Financial to Edit Title Performance ($ in millions excl. EPS) Sales Adj. EBITDA Margin* Adj. EPS* Free Cash Flow* Flat Organic* -150 bps -10% -7% 28.4% 26.9% $793 $798 $2.12 $206 $1.90 $192 Q3'23 Q3'24 Q3'23 Q3'24 Q3'23 Q3'24 Q3'23 Q3'24 Organic* FX M&A YoY∆ Sales Growth 0% 0% 1%
Slide 7: Q3 2024 Adjusted EBITDA Walk
Q3 Click 2024 Here Adjusted to Edit Title EBITDA Walk ($ in millions) 3Q’23 Act Volume Flow Price / Mix Resource Acq / Div / FX 3Q’24 ACT Adj. EBITDA Thru Productivity / Investment / Adj. EBITDA Inflation Discretionary Flow thru @ Organic flow Total flow PY GM%* thru** through 44.2% Unfavorable Unfa
Slide 8: Q3 2024: Fluid & Metering Technologies
Q3 Click 2024: HereFluid to Edit & Metering Title Technologies ($ in millions) Orders Sales Adj. EBITDA Margin* Highlights Flat% Organic* +2% Organic* -160 bps • Municipal Water remains healthy • Energy market softness 34.4% 32.8% • Ag down cycle $294 $290 $301 $301 • Higher employee/discretionary c
Slide 9: Q3 2024: Health & Science Technologies
Q3 Click 2024: HereHealth to Edit&Title Science Technologies ($ in millions) Orders Sales Adj. EBITDA Margin* Highlights +20% Organic* -5% Organic* -40 bps • Life Sciences & Analytical Instrumentation steady $330 26.9% 26.5% • Semiconductor delayed inflection $313 $311 $265 • Industrials projects co
Slide 10: Q3 2024: Fire & Safety / Diversified Products
Q3 Click 2024: HereFire to Edit & Safety Title / Diversified Products ($ in millions) Orders Sales Adj. EBITDA Margin* Highlights +4% Organic* +4% Organic* -20 bps • Fire NA OEM continued production ramp • BAND-IT Aero strength $163 $181 $188 $155 29.3% 29.1% • Dispensing NA headwind partially offse
Slide 11: 2024 Guidance Summary
2024 Click Here Guidance to Edit Summary Title Fourth Quarter Full Year Current Guidance Current Guidance Revenue % vs Prior Year Organic* 3% – 4% (2%) - (1%) EBITDA % Adjusted* ~27% ~27% Earnings Per Share Reported* $1.64 - $1.69 $6.65 - $6.70 Earnings Per Share Adjusted* $2.01 - $2.06 $7.85 - $7.9
Slide 12: IDEX Value Drivers
IDEXHere Click ValuetoDrivers Edit Title ORGANIC INORGANIC MARGIN GROWTH GROWTH EXPANSION • Leading market entitlement • Strong funnel of M&A opportunities • Leading the IDEX Op Model • Pricing Execution • Fast growing companies • 80/20 • Growth Bets Prioritization • Disciplined capital deployment •
Slide 13: Non-GAAP Reconciliations
Click Here to Edit Title Non-GAAP Reconciliations
Slide 14: Table 1: Reconciliations of the Change in Net Sales to Organic Net Sales
Table 1: Reconciliations of the Change in Net Sales to Organic Net Sales FMT HST FSDP IDEX Three Months Ended September 30, 2024 Change in net sales —% (1%) 4% 1% Less: Net impact from acquisitions/divestitures(1) (3%) 4% —% 1% Impact from foreign currency 1% —% —% —% Change in organic net sales 2%
Slide 15: Table 3: Reconciliations of Reported-to-Adjusted Net Income and Diluted EPS
Table 3: Reconciliations of Reported-to-Adjusted Net Income Attributable to IDEX and Diluted EPS Attributable to IDEX (in millions, other than per share amounts) Three Months Ended Nine Months Ended September 30, September 30, 2024 2023 2024 2023 Reported net income attributable to IDEX $ 119.1 $ 20
Slide 16: Table 4: Reconciliations of Net Income to Adjusted EBITDA
Table 4: Reconciliations of Net Income to Adjusted EBITDA (dollars in millions) Three Months Ended Nine Months Ended September 30, September 30, 2024 2023 2024 2023 Reported net income $ 118.9 $ 209.0 $ 381.4 $ 487.3 Provision for income taxes 35.5 52.8 106.7 132.8 Interest expense - net 10.3 13.7 2
Slide 17: Table 5: Reconciliations of Cash Flows from Operating Activities to Free Cash Flow
Table 5: Reconciliations of Cash Flows from Operating Activities to Free Cash Flow (dollars in millions) Three Months Ended September 30, Nine Months Ended September 30, 2024 2023 2024 2023 Cash flows from operating activities $ 205.3 $ 226.6 $ 495.5 $ 515.7 Less: Capital expenditures 13.7 20.1 49.6
Slide 18: Table 8: Reconciliation of Estimated 2024 Net Income to Adjusted EBITDA
Table 8: Reconciliation of Estimated 2024 Net Income to Adjusted EBITDA (dollars in millions) Guidance Fourth Quarter 2024 Full Year 2024 Low End High End Low End High End Estimated Reported net income $ 123.1 $ 127.4 $ 504.5 $ 508.8 Provision for income taxes 38.0 39.4 144.7 146.1 Interest expense